Clinical Trial Update: Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating CRN04894 for safety, efficacy, and pharmacokinetics in congenital adrenal hyperplasia has completed enrollment and status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classic Congenital Adrenal Hyperplasia
• Congenital Adrenal Hyperplasia

Drugs mentioned

• CRN04894

Snippet

Sponsor: Crinetics Pharmaceuticals Inc. | Conditions: Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia | Phase 2 | Status: COMPLETED